Minimally Invasive Surgical Instruments Market Global Market Report 2024

Minimally invasive surgical instruments are employed to conduct surgeries with minimal trauma to patients. This approach involves small incisions and requires only a few stitches. During the procedure, one or more small incisions are made in the body, and a laparoscope - a slender, tube-like device equipped with a light and a lens for visualization - is introduced through one of the openings to guide the surgery. Minimally invasive surgery offers advantages such as reduced discomfort, minimal scarring, less tissue damage, and a quicker recovery time compared to traditional surgery.

The array of minimally invasive surgical instruments comprises handheld instruments, inflation systems, cutter instruments, guiding devices, electrosurgical devices, and auxiliary instruments. These instruments are utilized for two types of procedure outlooks: robotic and non-robotic, across various applications including cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic and bariatric surgery, vascular surgery, and urological surgery. End-users of these instruments encompass hospitals, ambulatory surgical clinics, and research institutes.

The minimally invasive surgical instruments market research report is one of a series of new reports that provides minimally invasive surgical instruments market statistics, including minimally invasive surgical instruments industry global market size, regional shares, competitors with a minimally invasive surgical instruments market share, detailed minimally invasive surgical instruments market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive surgical instruments industry. This minimally invasive surgical instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The minimally invasive surgical instruments market size has grown rapidly in recent years. It will grow from $36.6 billion in 2023 to $40.42 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth observed in the historical period can be attributed to factors such as an aging population, an increase in chronic diseases, higher investments in research and development within the healthcare sector, enhanced healthcare infrastructure, and a surge in medical tourism.

The minimally invasive surgical instruments market size is expected to see strong growth in the next few years. It will grow to $59.17 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The anticipated growth in the forecast period is linked to factors such as the escalation in surgical volume, a rise in healthcare expenditure, increasing disposable income, and a demand for shorter hospital stays. Significant trends expected during this period encompass the integration of robotics and artificial intelligence (AI), the development of personalized surgical instruments, the adoption of sustainable and eco-friendly instruments, and an emphasis on cross-disciplinary collaborations.

The growth in the number of surgical procedures is anticipated to drive the expansion of the minimally invasive surgical instruments market. Medical professionals prefer minimally invasive surgery due to its lesser impact and reduced pain on the human body compared to open surgery. This approach is commonly employed in various procedures such as adrenalectomy, brain surgery, heart surgery, kidney transplant, spine surgery, and plastic and cosmetic surgery. For instance, in April 2022, the Aesthetic Society reported that the average plastic surgeon performed 320 surgical operations, up from 220 in 2020. Moreover, the number of surgical procedures for plastic and cosmetic surgery witnessed a 54% increase in 2021. Consequently, the rise in surgical procedures is fueling the growth of the minimally invasive surgical instruments market.

The increase in chronic diseases is expected to contribute to the growth of the minimally invasive surgical instruments market in the future. Chronic diseases, which are prolonged medical conditions lasting three months or more, are on the rise. Advanced minimally invasive surgical instruments enable surgeons to perform intricate procedures with smaller incisions, resulting in reduced pain, minimized scarring, shorter hospital stays, and faster recovery, particularly beneficial for patients with chronic diseases. According to a January 2023 report from the National Library of Medicine, the number of individuals aged 50 and older with one or more chronic illnesses is projected to increase by 99.5%, reaching 142.66 million by 2050 in the United States, up from 71.522 million in 2020. Therefore, the surge in chronic diseases is set to drive the growth of the minimally invasive surgical instruments market.

The development of low-cost surgical robotic systems is a notable trend gaining traction in the minimally invasive surgical instrument market. With the increasing demand for minimally invasive surgical instruments, robot-assisted surgery has become popular. New surgical modalities featuring smaller dimensions and lower costs are emerging. In June 2023, CMR Surgical, a UK-based medical device company, launched Versius, a small and modular surgical robot, in Belgium, aiming to expand access to minimally invasive surgery. Versius' adaptability allows it to fit any operating room, making it user-friendly for surgeons and hospitals. Its modularity enables customized port placement, enhancing versatility across various procedures and specialties while maximizing patient access to minimally invasive surgery.

Major companies in the minimally invasive surgical instruments market are introducing innovative products such as surgical visualization platforms to maintain a competitive edge. A surgical visualization platform provides high-quality, real-time images of the surgical site. In September 2022, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, unveiled the VISERA ELITE III, offering diverse observation options for a comprehensive view of the surgical environment. The system integrates multiple observation modes and fluorescence-guided surgery in 4K, enhancing surgical outcomes and facilitating minimally invasive treatments. Anticipated software upgrades are expected to further enhance surgical imaging technology, providing customization for various surgical requirements and reducing overall costs.

In April 2021, Erbe Elektromedizin, a Germany-based surgical tool and device manufacturer, signed an agreement to acquire Maxer Endoscopy GmbH for an undisclosed amount. This acquisition is expected to bolster Erbe's surgical endoscopy business and enhance its capabilities in endoscopic and open operations using 4K and fluorescence-guided devices. Maxer Endoscopy GmbH is a Germany-based company specializing in the development of high-end visualization technologies for minimally invasive surgery (MIS).

Major companies operating in the minimally invasive surgical instruments market market include Abbott Laboratories Inc., Aesculap Inc., AMNOTEC International Medical GmbH, Applied Medical Resources Corporation, B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, EndoMed Systems GmbH, FUJIFILM Holdings Corporation, HOYA Corporation, Intuitive Surgical Inc., KARL STORZ SE & Co. KG, KLS Martin Group, Koninklijke Philips N.V, Microline Surgical Corp., NuVasive Inc., Olympus Corporation, Scanlan International Inc., Smith & Nephew PLC, Ethicon Inc., GE Healthcare Technologies Ltd., Medtronic Inc., Johnson & Johnson Services Ltd., Stryker Corporation, Cooper Companies Inc., Applied Medical Technology Inc., Richard Wolf GmbH, Zimmer Biomet Holdings Inc., Siemens Healthineers AG

North America was the largest region in the minimally invasive surgical instruments market in 2023. Asia-Pacific is expected to be the fastest growing region in the minimally invasive surgical instruments market. The regions covered in the minimally invasive surgical instruments market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the minimally invasive surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The minimally invasive surgical instruments consist of sales of retractors/elevators, suturing instruments, dilators, inflation devices (balloons), cutter instruments (trocars), guiding devices (guiding catheters, guidewires), auxiliary instruments, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.